FDA Inspection 1207365 — Auro PR Inc

Auro PR Inc — FEI 2650176

The FDA completed an inspection of Auro PR Inc on May 31, 2023 in Caguas, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Caguas, PR (United States)

Citations

IDCFRDescription
188521 CFR 211.165(b)Microbiological testing
192221 CFR 211.166(a)(4)Testing in same container - closure system